Skip to main content

US ClosedU.S. Closed

ALDX: Aldeyra The Stock Analysis | finqOS

Healthcare · Biotechnology

Aldeyra Therapeutics, Inc. , a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.

52W Range

9thpctl

Volume

0.45×avg

Market Cap

89.58MUSD

P/E Ratio

-3.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Aldeyra The

ALDXNASDAQ·USD·Closed

Aldeyra The

ALDXNASDAQ·USD·Closed

$1.49

−3.57%

$1.49

−$0.05 (3.57%)

52W Range

9thpctl

Volume

0.45×avg

Mkt Cap

89.58MUSD

P/E

-3.8TTM

Div Yield

–ann